Sub-phenotyping in critical care: a valuable strategy or methodologically fragile path?

Intensive Care Med Exp

Pattern Recognition & Bioinformatics Group, Delft University of Technology, Delft, The Netherlands.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141183PMC
http://dx.doi.org/10.1186/s40635-025-00769-1DOI Listing

Publication Analysis

Top Keywords

sub-phenotyping critical
4
critical care
4
care valuable
4
valuable strategy
4
strategy methodologically
4
methodologically fragile
4
fragile path?
4
sub-phenotyping
1
care
1
valuable
1

Similar Publications

Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial.

Anaesth Crit Care Pain Med

May 2025

Center for Anesthesia Research Excellence, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Bos

Background: International guidelines have emphasized the necessity of evaluating the temporal stability of acute respiratory distress syndrome (ARDS) subphenotypes. This study aimed to assess the temporal stability of subphenotypes of ARDS over 28 days.

Methods: A reanalysis of a randomized trial was conducted, including patients with COVID-19-related moderate-to-severe ARDS across 43 centers.

View Article and Find Full Text PDF

Acute kidney injury (AKI) is a common condition in intensive care units (ICUs) and is associated with high mortality rates, particularly when kidney replacement therapy (KRT) becomes necessary. The optimal timing for initiating KRT remains a subject of ongoing debate. Emerging tools and methodologies, such as machine learning and advanced sub-phenotyping, offer promising insights into refining AKI management.

View Article and Find Full Text PDF

Advancing surgical outcomes through cardiovascular biomarker sub-phenotyping.

Br J Anaesth

May 2025

Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA; French Clinical Research Infrastructure Network Initiative-Cardio Renal Clinical Trialists Network, Nancy, France. Electronic address: matthieu

Recent findings from Gutierrez del Arroyo and colleagues identified distinct sub-phenotypes in patients undergoing major noncardiac surgery based on biomarkers such as N terminal pro-brain natriuretic peptide, renin, aldosterone, and angiotensin-converting enzyme 2, which were associated with varying risks of postoperative myocardial injury. Although their findings highlight the potential of sub-phenotyping for advancing perioperative precision medicine, further research is needed to validate these sub-phenotypes and explore their role in tailoring perioperative management strategies.

View Article and Find Full Text PDF